Adicet Bio is a biotechnology company that develops therapies for cancer diseases. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) for selective tumor targeting and to enhance the immune response. The company also develops proprietary cell platform processes to activate, engineer, and expand gamma delta T cells.